NEU 2.04% $15.52 neuren pharmaceuticals limited

Ann: Q1 2024 quarterly activity and cash flow report, page-16

  1. 2,848 Posts.
    lightbulb Created with Sketch. 558
    Neuren management would be receiving regular Daybue QI 2024 sales updates from Acadia.In my view it would be out of character for this companys management to indicate Acadia's sales guidance numbers in a 4C report if sales were not somewhere near the mark.No business runs properly without timely and up to date financials.
    The US$76M-$82M quoted revenues for Q! 2024 are on the low side compared to the full years anticipated net sales.
    Kens
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.52
Change
0.310(2.04%)
Mkt cap ! $1.983B
Open High Low Value Volume
$15.19 $15.62 $15.11 $8.655M 558.4K

Buyers (Bids)

No. Vol. Price($)
1 440 $15.48
 

Sellers (Offers)

Price($) Vol. No.
$15.54 752 1
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.